Status: Recruiting
Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
The goal of this clinical trial is to evaluate the safety and tolerability of RCS-21 in healthy volunteers. Participants will be asked to inhale a single dose of RCS-21 and their health status will be constantly monitored.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18-64Biological sex: AllType: InterventionalSponsor: RNATICS GmbHUpdated: Nov 20, 2025Locations: 1
Eligibility criteria
Able and willing to give written informed consent. [+24]
Any clinically relevant abnormal findings in physical examination, clinical chem... [+20]